Ampio Pharmaceuticals, Inc.
AMPE
$0.01
-$0.14-96.39%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.15% | -11.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 58.21% | -10.26% | |||
| Operating Income | -58.21% | 10.26% | |||
| Income Before Tax | -67.13% | 10.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67.13% | 10.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -67.13% | 10.36% | |||
| EBIT | -58.21% | 10.26% | |||
| EBITDA | -58.21% | 10.26% | |||
| EPS Basic | -62.32% | 15.87% | |||
| Normalized Basic EPS | -62.40% | 15.87% | |||
| EPS Diluted | -62.44% | 15.78% | |||
| Normalized Diluted EPS | -62.40% | 15.87% | |||
| Average Basic Shares Outstanding | 2.96% | 6.56% | |||
| Average Diluted Shares Outstanding | 2.96% | 6.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||